Skip to main content
Livermore
Livermore
ZHEN

Quadrant Capital Group LLC

SEC CIK
0001650717
Latest filing
Aug 14, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of BMRN by Quadrant Capital Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−20,772−100.0%Sold outHolders
Q1 202620,772$1.17M<0.1%+1,436+7.4%AddedHolders
Q4 202519,336$1.15M<0.1%+14,918+337.7%AddedHolders
Q3 20254,418$239.3K<0.1%−7,740−63.7%ReducedHolders
Q2 202512,158$668.3K<0.1%+1,148+10.4%AddedHolders
Q1 202511,010$778.3K<0.1%+9,234+519.9%AddedHolders
Q4 20241,776$116.7K<0.1%+658+58.9%AddedHolders
Q3 20241,118$78.6K<0.1%+687+159.4%AddedHolders
Q2 2024431$35.5K<0.1%+266+161.2%AddedHolders
Q1 2024165$14.4K<0.1%+14+9.3%AddedHolders
Q4 2023151$14.6K<0.1%+19+14.4%AddedHolders
Q3 2023132$11.7K<0.1%−327−71.2%ReducedHolders
Q2 2023459$39.8K<0.1%−62−11.9%ReducedHolders
Q1 2023521$50.7K<0.1%+290+125.5%AddedHolders
Q4 2022231$23.9K<0.1%−17−6.9%ReducedHolders
Q3 2022248$21.0K<0.1%−107−30.1%ReducedHolders
Q2 2022355$29.0K<0.1%+232+188.6%AddedHolders
Q1 2022123$9.00K<0.1%−120−49.4%ReducedHolders
Q4 2021243$21.0K<0.1%+8+3.4%AddedHolders
Q3 2021235$18.0K<0.1%−10−4.1%ReducedHolders
Q2 2021245$20.0K<0.1%−104−29.8%ReducedHolders
Q1 2021349$26.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.